The ROE as of September 2024 (TTM) for Rigel Pharmaceuticals, Inc. (RIGL) is 46.64%

According to Rigel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 46.64%. This represents a change of 316.50% compared to the average of 11.20% of the last 4 quarters.

Rigel Pharmaceuticals, Inc. (RIGL) Historical ROE (quarterly & annually)

How has RIGL ROE performed in the past?

The mean historical ROE of Rigel Pharmaceuticals, Inc. over the last ten years is -12.66%. The current 46.64% ROE has changed -468.39% with respect to the historical average. Over the past ten years (40 quarters), RIGL's ROE was at its highest in in the June 2022 quarter at 381.26%. The ROE was at its lowest in in the March 2022 quarter at -421.14%.

Rigel Pharmaceuticals, Inc. (RIGL) ROE by Quarter and Year

Discovering the peaks and valleys of Rigel Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rigel Pharmaceuticals, Inc. (RIGL) Average ROE

How has RIGL ROE performed in the past?

The current ROE of Rigel Pharmaceuticals, Inc. (RIGL) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Rigel Pharmaceuticals, Inc. (RIGL) ROE vs. Peers

How is RIGL’s ROE compared to its peers?

Rigel Pharmaceuticals, Inc.’s ROE is greater than Fortress Biotech, Inc. (-226.63%), less than Reviva Pharmaceuticals Holdings, Inc. (7.96%), less than CTI BioPharma Corp. (180.42%), greater than Ocuphire Pharma, Inc. (-30.19%), less than Nabriva Therapeutics plc (6.00%), greater than Eiger BioPharmaceuticals, Inc. (-869.84%), greater than Pieris Pharmaceuticals, Inc. (-97.28%), greater than Cidara Therapeutics, Inc. (-401.89%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Mereo BioPharma Group plc (-63.39%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Leap Therapeutics, Inc. (-98.01%), greater than Zura Bio Limited (-35.45%), greater than Enveric Biosciences, Inc. (-234.16%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Immix Biopharma, Inc. (-86.48%), greater than Elevation Oncology, Inc. (-57.97%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than VectivBio Holding AG (-56.92%),

Build a custom stock screener for Rigel Pharmaceuticals, Inc. (RIGL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rigel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rigel Pharmaceuticals, Inc. (RIGL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rigel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.